Cargando…
Efficacy and Safety of GHX02 in the Treatment of Acute Bronchitis and Acute Exacerbation of Chronic Bronchitis: A Phase Ⅱ, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
Acute bronchitis and acute exacerbations of chronic bronchitis (AECB) have cough and sputum as the main symptoms with a high prevalence and substantial economic burden. Although the demand for bronchitis treatment increases due to causes, such as air pollution, the appropriateness of antibiotic pres...
Autores principales: | Lee, Su Won, Lyu, Yee Ran, Kim, Si Yeon, Yang, Won Kyung, Kim, Seung Hyung, Kim, Ki Mo, Chae, Sung-Wook, Kang, Weechang, Jung, In Chul, Park, Yang Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801800/ https://www.ncbi.nlm.nih.gov/pubmed/35111046 http://dx.doi.org/10.3389/fphar.2021.761575 |
Ejemplares similares
-
Efficacy and safety of GHX02 in the treatment of acute bronchitis: protocol of a phase II, double-blind, randomised placebo-controlled trial
por: Lyu, Yee Ran, et al.
Publicado: (2018) -
Assessment of the 4‐week repeated‐dose oral toxicity and genotoxicity of GHX02
por: Ji, Kon‐Young, et al.
Publicado: (2019) -
Acute Bronchitis
por: Walsh, Edward E.
Publicado: (2015) -
Acute Bronchitis
Publicado: (1900) -
Role of Atypical Pathogens and the Antibiotic Prescription Pattern in Acute Bronchitis: A Multicenter Study in Korea
por: Park, Sunghoon, et al.
Publicado: (2015)